Filing Flows › Comparisons › VRCA vs PRLD
Verrica Pharmaceuticals vs Prelude Therapeutics: VRCA and PRLD compared
Verrica Pharmaceuticals is the larger company: $5.9M of revenue in its latest quarter (Q2 2026) against $5.7M for Prelude Therapeutics (Q2 2026). Verrica Pharmaceuticals is more profitable, with an operating margin of -223.4% against -270.9%.
Where the money goes: VRCA and PRLD
Verrica Pharmaceuticals (VRCA) · Q2 2026
Verrica Pharmaceuticals, Q2 2026: revenue $5.9M (-54% year over year), operating margin -223.4%, net loss $13.2M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
Prelude Therapeutics (PRLD) · Q2 2026
Prelude Therapeutics, Q2 2026: revenue $5.7M, operating margin -270.9%, net loss $13.9M, operating cash flow −$15.6M. The chart follows the revenue to costs, profit and cash.
| Verrica Pharmaceuticals (VRCA) | Prelude Therapeutics (PRLD) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $5.9M | $5.7M |
| Revenue growth, Y/Y | -54% | — |
| Operating margin | -223.4% | -270.9% |
| Net earnings | −$13.2M | −$13.9M |
| Net margin | -224.4% | -244.1% |
| Operating cash flow | −$9.3M | −$15.6M |
Questions
Which is bigger, Verrica Pharmaceuticals or Prelude Therapeutics?
Verrica Pharmaceuticals is the larger company: $5.9M of revenue in its latest quarter (Q2 2026) against $5.7M for Prelude Therapeutics (Q2 2026).
Is Verrica Pharmaceuticals or Prelude Therapeutics growing faster?
Verrica Pharmaceuticals is more profitable, with an operating margin of -223.4% against -270.9%.
More: Verrica Pharmaceuticals earnings · how Verrica Pharmaceuticals makes money · Prelude Therapeutics earnings · how Prelude Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.